ArticleBritish journal of cancer2012

Differential downregulation of telomerase activity by bortezomib in multiple myeloma cells-multiple regulatory pathways in vitro and ex vivo.

C Weiss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.